Prevention of Future Deaths reports · 2023

Katie Williams

Regulation 28 report to prevent future deaths, reference 2023-0512, written 24 Nov 2023. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report24 Nov 2023
Reference2023-0512
DeceasedKatie Williams
CoronerLouise Wiltshire
Coroner areaPlymouth, Torbay and South Devon
CategoryAlcohol, drug and medication related deaths · Suicide (from 2015)
Organisation namedUniversity Hospitals Plymouth NHS Trust
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

Philip Spinney His Majesty’s Senior Coroner  
for the County of  Devon 
Plymouth, Torbay and South Devon Coroner Service 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO:   

The Faculty of Intensive Care Medicine  
Churchill House 
35 Red Lion Square  
London  
WC1R 4SG 

1 

CORONER 

I am Louise Wiltshire, Assistant Coroner for Plymouth Torbay and South Devon                    

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 
2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 
http://www.legislation.gov.uk/ukpga/2009/25/schedule/5/paragraph/7 
http://www.legislation.gov.uk/uksi/2013/1629/part/7/made 

3 

INVESTIGATION and INQUEST 

On 11 June 2021 an inquest was opened touching the death of Katie Anne 
WILLIAMS (aged 45) who died at Derriford Hospital in Plymouth on 24 May 2021.  
She died having taken intentional overdose of 
 on 15 May 2021, and as 
a result of subsequent hospital care and treatment provided to her for that 
overdose and associated complications.   

The inquest concluded on 23 November 2023 with the following narrative 
conclusion:  

"Katie Anne Williams died on 24 May 2021 from serotonin toxicity caused by an 
overdose of 

 and hospital administered 

." 

In Box 3 of the record of inquest:  

"Katie Anne Williams died on 24 May 2021 at Derriford Hospital. On 16 May 2021, 
she took an overdose of 
. She was admitted to hospital where she was 
treated for this overdose and associated complications, including an aspiration 
pneumonia and paralytic ileus. 
 was initially withheld given the risk of 
serotonin toxicity, but re-introduced on day four of her ICU stay, as the period of 
risk for serotonin toxicity was felt to have passed. Sadly, as a result of the paralytic 
ileus Katie had developed, the absorption of modified release 
delayed.  This, in combination with 
precipitation of serotonin toxicity which was ultimately fatal." 

 administered in the ICU caused a re-

 was 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The medical cause of death was recorded at the inquest as:  

1a) Circulatory failure  
1b) Serotonin toxicity  
1c) Drug overdose 

As part of the inquest it was found as a matter of fact that the 
by the ICU team in the hospital (as part of their standard procedure for sedating 
intubated patients) had caused a reprecipitation of the serotonin toxicity which was 
previously thought to have resolved.  This was thought to have occurred because 
the patient had developed a paralytic ileus which had delayed the absorption of the 
 she had taken prior to her admission.  This caused or 
modified release 
contributed to Katie's death.  

 administered 

Following this case the University Hospitals Plymouth NHS Trust (the "Trust") has 
amended its sedation policy such that lower risk opiates (such as morphine) are 
recommended for sedating patients who are admitted following overdose of 
medications like venlafaxine, to reduce the risk of reprecipitating serotonin toxicity.  

4 

CIRCUMSTANCES OF THE DEATH 

On 15 May 2021 Katie Anne WILLIAMS took an overdose of her prescribed 

.  She had taken 

 modified release tablets.  

Equivalent to 56 days' worth of this prescribed medication.  

She was taken to Derriford Hospital by ambulance in the early hours of 16 May 
2021 where she was reviewed in the emergency department and then shortly 
afterwards admitted to ICU.  

On arrival at the emergency department, Katie was recognised to be extremely 
unwell.  She was unconscious with a GCS of 3 as a result of her overdose. She 
had also had a number of seizures on her way to the hospital, and prior to the 
ambulance arrival.  She required intubation and ventilation to protect her airway 
and stabilise her condition.  

A chest x-ray was undertaken which demonstrated evidence of an aspiration. Katie 
also had a temperature of 40°c on admission to the emergency department; this, 
and the evidence of early muscle injury, led the treating ICU team to conclude that 
Kate was likely to be suffering with serotonin toxicity.  

Given the ongoing risk of serotonin toxicity, and following Toxbase advice, no 
infusion of the opiate drug 
of her ICU admission. At this stage, the venlafaxine was felt to still to be her 
system, and the plan was to support Katie whilst this cleared, and to treat her 
evolving aspiration pneumonia with antibiotics.  Where additional sedation was 
required remifentanil was used.  

 was administered to Katie during days 1, 2 or 3 

On day 4 of Katie‘s ICU admission (19 May 2021) a decision was made to switch 
the remifentanil infusion to a 
following days Katie‘s kidney function continue to normalise. There was no 
recurrence of a hyperpyrexia, or any other clinical features to suggest a recurrence 
of the serotonin syndrome.  

 infusion as per usual ICU practice. In the 

 
 
 
 
 
 
 
 
 
 
 
 
 The rationale for moving to 
the majority of the venlafaxine would have been metabolised by the body and 
therefore the risk of interaction with any other drugs such as fentanyl would not 
have been a significant concern.  

 was that from day three onwards it was felt that 

 was infused on an hourly basis in accordance with usual practice and 

tolerance of the drug was monitored based on clinical effect, including considering 
a patient’s tolerance of the ET tube and interrupting the infusion on a regular basis 
to check for drug accumulation.  

Sadly, over the next few days, Katie‘s condition deteriorated.  A CT scan confirmed 
the appearances of severe aspiration pneumonia and a paralytic ileus.  

The concern at day five was the evolving severe aspiration pneumonia. Katie was 
now severely ill. As a result of this she required ventilating in the prone position. 
 infusion was 
Prone ventilation required heavy sedation and as such the 
increased to 5ml/hr. At this stage, it was felt that the 
passed.  

 poisoning had 

Over the coming days Katie‘s condition improved, and she was able to be 
managed once again in the standard supine position. The 
reduced from 5 ml/hour to 3 ml/hour.  She was having regular sedation breaks from 
which she was rousing quickly which meant that the infusion could not be further 
reduced. Again at this stage, the risk of an ongoing serotonin toxicity was not 
considered to be an issue. 

 infusion was 

Katie had also developed a paralytic ileus. In Katie‘s case the paralytic ileus (it 
appears) delayed the absorption of the modified release 
that the ICU team treating her at the time felt that the 
her system, and that it was therefore safe to introduce 
hindsight, and having seen the toxicology report, it appears that that was not the 
case; Katie still had a significant amount of 
 in her system.  I am told 
there is no way of monitoring these levels in life.  

. This meant 
 had cleared from 
.  With the benefit of 

In the morning of 24 May 2021 Katie appeared to be improving. She was reviewed 
on the ward round at 11am. She was haemodynamically stable, requiring no drugs 
to support her blood pressure.  He abdomen remained distended, but there was no 
particular clinical concern for this at the time the plan was to continue with 
supportive care in the expectation she would continue to improve in the days 
ahead.   

Very sadly however, and suddenly, Katie‘s condition began to deteriorate at around 
1pm that day. Her blood pressure began to drop and a noradrenaline infusion was 
commenced.  Over the course of the afternoon her blood chemistry steadily 
deteriorated, reflecting her increasingly shocked state. Her oxygen requirement 
increased and she developed a severe refractory, circulatory failure and associated 
pulmonary oedema. Initially the team thought that Katy had become septic and that 
there might be an acute pathology such as a bowel ischemia or perforation. It was 
therefore decided to take Katie for a CT scan. However, sadly, whilst preparing 
Katy for transfer to the CT scanner she went into cardiac arrest. Attempts were 
made to resuscitate her over the following 40 minutes, but there was no reversible 
cause for the cardiac arrest that could be identified. Katy did not respond and 
resuscitation efforts ceased at 19:10 hours. 

 
 
 
 
 
 
 
 
 Retrospectively, treating clinicians have considered the cause for Katie‘s collapse 
on 24 May 2021. Having reviewed the toxicology report they are of the view that 
the paralytic ileus delayed the absorption of the modified release 
combined with the 
 (that was used as a sedative drug in accordance with 
standard practice in the ICU setting) had reprecipitated a serotonin toxicity, which 
caused Katie to collapse on the 24 May 2021.  It is their view that Katie‘s death 
was caused by a very unusual and rare presentation of a serotonin toxicity that 
occurred as a result of the delayed absorption of the 
paralytic ileus, and an idiosyncratic reaction between the 

, because of the 
 and the 

.  This, 

Following Katie's death, the ITU team has amended its sedation policy such that 

would now be replaced with morphine in cases such as Katie's, where 

patients presenting with a 
serotonin toxicity. 

 (or similar) where there is an ongoing risk of 

5 

CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to 
concern. In my opinion there is a risk that future deaths will occur unless action is 
taken. In the circumstances it is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows.  –  

 from day four of Katie's hospital admission 

The administration of 
reprecipitated her serotonin syndrome and directly contributed to her death.  The 
Trust has recognised this and amended its sedation policy to recommend "lower 
risk" opiates (such as morphine) are used in patients who have taken overdoses of 
medications where there is a risk of serotonin syndrome / toxicity.   

 interacted in this case was 
It is accepted that the way the 
unexpected, and appears to have occurred due to the particular circumstances of 
Katie's case; in particular an aspiration pneumonia requiring treatment in the prone 
position, and the development of a paralytic ileus.  However, these complications 
are not unusual in patients who have taken overdoses of these types of 
medications and as such I consider there is a risk a future death may occur in 
similar circumstances.   

I am concerned that other NHS organisations may not fully appreciate the risks 
associated with the use of 
information should be shared with those organisations on a national level.  

 in patients such as Katie and that this 

  
 
 
 
 
 
 
 
 
 
 
 
 6 

ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe your 
organisation has the power to take such action.  

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this 
report, namely by 5 January 2024. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, 
setting out the timetable for action. Otherwise you must explain why no action is 
proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to the following 
Interested Persons: 

University Hospitals Plymouth NHS Trust 
Family members of Katie Anne Williams 

I am also under a duty to send the Chief Coroner a copy of your response and all 
Interested Persons who in my opinion should receive it.  

The Chief Coroner may publish either or both in a complete or redacted or 
summary form. He may send a copy of this report to any person who he believes 
may find it useful or of interest. You may make representations to me, the coroner, 
at the time of your response, about the release or the publication of your response 
by the Chief Coroner. 

9 

Dated:  24 November 2023 

Louise WILTSHIRE, Assistant Coroner for Plymouth, Torbay and South Devon  

Signature_________________________ 

1, Derriford Business Park, Derriford Park, Plymouth PL6 5QZ

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from University Hospitals Plymouth NHS Trust (PDF)
Chief Medical Officer 
University Hospitals Plymouth NHS Trust 
Derriford Road 
Crownhill 
Plymouth 
PL6 8DH 

14th December 2023 

Ms Louise Wiltshire 
Assistant Coroner for Plymouth Torbay & South Devon 
1, Derriford Business Park 
Derriford Park  
PLYMOUTH  PL6 5QZ 

Dear Ms Wiltshire 

Re :   Inquest touching the death of Katie Anne WILLIAMS (aged 45) 

Inquest Date : 23rd November 2023 

At  the  conclusion  of  the  above  referenced  inquest,  you  determined  that  under  the 
powers  granted  to  you  by  paragraph  7,  schedule  5  of  the  Coroner  and  Justice  Act 
2009 and Regulations 28 and 29 of the Coroner (Investigations) Regulations 2013 that 
you would write to The Faculty of Intensive Care Medicine with a Preventing Future 
Deaths Report and a copy has been provided to our Trust. 

We  have  now  received  that  report  and  note  your  concerns  that  other  NHS 
organisations may not fully appreciate the risks associated with the use of fentanyl in 
patients  such  as  Katie  and  that  this  information  should  be  shared  with  those 
organisations on a National level.  

Cont’d / ……. 

Working in partnership with the Peninsula Medical School 

 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page 02 of 02 

We  write  to  assure  you  that  University  Hospitals  Plymouth  NHS  Trust  has  been  in 
contact with The Faculty of Intensive Care Medicine to assist with sharing the relevant 
information  to  enable  them  to  share  at  a  National  level.  We  have  also  taken  the 
decision to communicate the issue with the SW Critical Care Network lead, and we 
will help them produce a regional advisory notice. 

We trust this response can further assure you of our commitment to ensure that wider 
learning has taken place. 

If we can be of any further assistance, please do not hesitate to contact us. 

Yours sincerely  

Chief Medical Officer 

Working in partnership with the Peninsula Medical School

Related reports

Other reports by Louise Wiltshire

See all →

More reports categorised “Alcohol, drug and medication related deaths”

See all →

Track University Hospitals Plymouth NHS Trust

See every Prevention of Future Deaths report matching University Hospitals Plymouth NHS Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.